Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (79)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baron, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baron, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 52:58-73 (1996)
© 1996 The British Council


research-article

Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious

John A. Baron

Department of Medicine, and Community and Family Medicine, Dartmouth Medical School Hanover, New Hampshire, USA

Abstract

Cigarette smoking is an established risk factor for cancer and cardiovascular disease, and is the leading cause of avoidable disease in most industrialized countries. Less well-known are possible beneficial effects, which are briefly considered in this survey.

Preliminary data suggest that there may be inverse associations of smoking with uterine fibroids and endometriosis, and protective effects on hypertensive disorders and vomiting of pregnancy are likely. Smoking has consistently been found to be inversely related to the risk of endometrial cancer, but cancers of the breast and colon seem unrelated to smoking. Inverse associations with venous thrombosis and fatality after myocardial infarction are probably not causal, but indications of benefits with regard to recurrent aphthous ulcers, ulcerative colitis, and control of body weight may well reflect a genuine benefit. Evidence is growing that cigarette smoking and nicotine may prevent or ameliorate Parkinson's disease, and could do so in Alzheimer's dementia. A variety of mechanisms for potentially beneficial effects of smoking have been proposed, but three predominate: the ‘anti-estrogenic effect’ of smoking; alterations in prostaglandin production; and stimulation of nicotinic cholinergic receptors in the central nervous system.

Even established inverse associations cannot be used as a rationale for cigarette smoking. These data can be used, however, to clarify mechanisms of disease, and point to productive treatment or preventive options with more narrowly-acting interventions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
R. Boynton-Jarrett, J. Rich-Edwards, S. Malspeis, S. A. Missmer, and R. Wright
A Prospective Study of Hypertension and Risk of Uterine Leiomyomata
Am. J. Epidemiol., April 1, 2005; 161(7): 628 - 638.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. B. Schabath, X. Wu, R. Vassilopoulou-Sellin, A. A. Vaporciyan, and M. R. Spitz
Hormone Replacement Therapy and Lung Cancer Risk: A Case-Control Analysis
Clin. Cancer Res., January 1, 2004; 10(1): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. A. Schoedel, E. M. Sellers, R. Palmour, and R. F. Tyndale
Down-Regulation of Hepatic Nicotine Metabolism and a CYP2A6-Like Enzyme in African Green Monkeys after Long-Term Nicotine Administration
Mol. Pharmacol., January 1, 2003; 63(1): 96 - 104.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
H. M. Fillit, R. N. Butler, A. W. O'Connell, M. S. Albert, J. E. Birren, C. W. Cotman, W. T. Greenough, P. E. Gold, A. F. Kramer, L. H. Kuller, et al.
Achieving and Maintaining Cognitive Vitality With Aging
Mayo Clin. Proc., July 1, 2002; 77(7): 681 - 696.
[Abstract] [PDF]


Home page
Int J EpidemiolHome page
S. C Ho, J. Woo, A. Sham, S. G. Chan, and A. L. Yu
A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort
Int. J. Epidemiol., December 1, 2001; 30(6): 1389 - 1396.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. D. Benedetti, J. H. Bower, D. M. Maraganore, S. K. McDonnell, B. J. Peterson, J. E. Ahlskog, D. J. Schaid, and W. A. Rocca
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: A case-control study
Neurology, November 14, 2000; 55(9): 1350 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
N. Hallquist, A. Hakki, L. Wecker, H. Friedman, and S. Pross
Differential Effects of Nicotine and Aging on Splenocyte Proliferation and the Production of Th1- Versus Th2-Type Cytokines
Experimental Biology and Medicine, July 1, 2000; 224(3): 141 - 146.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. BEHR, B. DEGENKOLB, T. BEINERT, F. KROMBACH, and C. VOGELMEIER
Pulmonary Glutathione Levels in Acute Episodes of Farmer's Lung
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1968 - 1971.
[Abstract] [Full Text]


Home page
BMJHome page
C. Brayne
Smoking and the brain
BMJ, April 22, 2000; 320(7242): 1087 - 1088.
[Full Text]


Home page
BMJHome page
R. Doll, R. Peto, J. Boreham, and I. Sutherland
Smoking and dementia in male British doctors: prospective study
BMJ, April 22, 2000; 320(7242): 1097 - 1102.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
R Manthorpe, C Benoni, L Jacobsson, Z Kirtava, A Larsson, R Liedholm, C Nyhagen, H Tabery, and E Theander
Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjogren's syndrome?
Ann Rheum Dis, January 1, 2000; 59(1): 54 - 60.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.